Who
Brett Matthew Hall
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Immuneering.
In numbers
- Trades disclosed
- 22
- Buys
- 8
- Sells
- 0
- Bought
- $164K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Aug 2021
- Last trade
- 15 Jun 2026
- Last filed
- 16 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 16 Jun 2026 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $25K6,035 at $4.15 | filing |
| 15 Jun 2026filed 16 Jun 2026 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $25K6,035 at $4.15 | filing |
| 3 Feb 2026filed 5 Feb 2026 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —344,000 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —344,000 at $0.00 | filing |
| 15 Jan 2026filed 16 Jan 2026 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $11K2,298 at $4.57 | filing |
| 15 Jan 2026filed 16 Jan 2026 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $11K2,298 at $4.57 | filing |
| 15 Sep 2025filed 17 Sep 2025 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Code A | $21K14,880 at $1.43 | filing |
| 23 Jun 2025filed 24 Jun 2025 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $15K6,007 at $2.43 | filing |
| 20 Jun 2025filed 24 Jun 2025 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $20K7,415 at $2.70 | filing |
| 5 Feb 2025filed 7 Feb 2025 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —240,000 at $0.00 | filing |
| 20 Mar 2024filed 21 Mar 2024 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $20K7,000 at $2.86 | filing |
| 15 Mar 2024filed 21 Mar 2024 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Code A | $10K6,211 at $1.62 | filing |
| 8 Feb 2024filed 9 Feb 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —130,900 at $0.00 | filing |
| 15 Feb 2023filed 17 Feb 2023 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —187,000 at $0.00 | filing |
| 25 May 2022filed 27 May 2022 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $10,0002,551 at $3.92 | filing |
| 23 Mar 2022filed 23 Mar 2022 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $8,3061,050 at $7.91 | filing |
| 10 Feb 2022filed 14 Feb 2022 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —83,100 at $0.00 | filing |
| 22 Dec 2021filed 22 Dec 2021 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Code A | —322,691 | filing |
| 3 Aug 2021filed 4 Aug 2021 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Code C | —5,040 | filing |
| 3 Aug 2021filed 4 Aug 2021 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $20K1,353 at $15.00 | filing |
News
No headline names them, or the companies they trade most, lately.